Navigation Links
Malaysian Scientists Publish the Very Latest Results on Colorectal Cancer Screening Using the M2-PK Rapid Test in the Renowned Journal PLOS ONE
Date:7/15/2015

KUALA LUMPUR, Malaysia, July 15, 2015 /PRNewswire/ --

Scientists from the Department of Medicine at the University of Malaysia have recently presented the very latest data from a study on colorectal cancer screening using the M2-PK stool test in the renowned publication PLOS ONE. These latest results for the M2-PK test from the cancer specialist Professor Khean-Lee Goh - one of the most renowned experts in Asia on this subject - and his colleagues confirm once again the exceptionally high capability and accuracy of the M2-PK test for colorectal cancer screening.

Professor Goh investigated the enyzme biomarker M2-PK in a patient group with 100 colorectal cancer cases and a population-based control group of 200 healthy people. The M2-PK test detected 93% of colorectal cancers. Furthermore, it recognized 97.5% of the control group as truly healthy. The positive predictive value for colorectal cancer was 94.9% and the predictive value to exclude colorectal cancer (negative predictive value) was 96.5%. The overall accuracy of the M2-PK test was 96%.

The investigators also made two additional important findings. Firstly, the M2-PK test has a very high detection rate (sensitivity) for right-sided (85.7%) as well as for left-sided colorectal cancers (94.2%). This result is especially important because right-sided colorectal cancers are more often missed than left-sided with conventional screening methods.

Secondly, M2-PK had almost the same very high rate of detection (sensitivity) across all four tumour stages (stage 1 = 94.1%; stage 2 = 88.9%; stage 3 = 96.4%; stage 4 = 90.3%).

The M2-PK rapid stool test is available for the doctors' practice as ScheBo®• M2-PK QuickTM (ScheBo• Biotech AG).

Source: K.-L. Goh, et al.: http://dx.doi.org/10.1371/journal.pone.0131616

ScheBo• Biotech AG / Tel: +49-(0)641-4996-0 / Fax: +49-(0)641-4996-78 http://www.schebo.com


'/>"/>
SOURCE ScheBo Biotech AG
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. From Autism to Diabetes to Parkinsons Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
2. NYU-Poly Nano Scientists Reach the Holy Grail in Label-Free Cancer Marker Detection: Single Molecules
3. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
4. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
5. Made in IBM Labs: Scientists Turn Data into Disease Detective to Predict Dengue Fever and Malaria Outbreaks
6. Scientists at HerbalScience Develop a Synergistic Method to Fight Antibiotic Resistant Bacteria
7. Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014
8. ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy
9. 2014 Lasker Awards Honor Scientists Who Addressed Key Questions In Biology And Medicine
10. Quantum Materials Corp to Quadruple Lab Space and Add Scientists
11. Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):